# | Title | Journal | Year | Citations |
---|
1 | Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings) | CNS Neuroscience and Therapeutics | 2013 | 486 |
2 | Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment | CNS Neuroscience and Therapeutics | 2017 | 390 |
3 | REVIEW: Curcumin and Alzheimer's Disease | CNS Neuroscience and Therapeutics | 2010 | 367 |
4 | The Pharmacology of Lysergic Acid Diethylamide: A Review | CNS Neuroscience and Therapeutics | 2008 | 351 |
5 | A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade? | CNS Neuroscience and Therapeutics | 2011 | 309 |
6 | Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders | CNS Neuroscience and Therapeutics | 2010 | 283 |
7 | Post‐Traumatic Stress Disorder in Canada | CNS Neuroscience and Therapeutics | 2008 | 274 |
8 | Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome | CNS Neuroscience and Therapeutics | 2016 | 262 |
9 | The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD) | CNS Neuroscience and Therapeutics | 2009 | 250 |
10 | Vilazodone: A 5‐HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders | CNS Neuroscience and Therapeutics | 2009 | 248 |
11 | REVIEW: Neurosyphilis: A Historical Perspective and Review | CNS Neuroscience and Therapeutics | 2010 | 243 |
12 | Brain structure alterations in depression: Psychoradiological evidence | CNS Neuroscience and Therapeutics | 2018 | 236 |
13 | Excessive Autophagy Contributes to Neuron Death in Cerebral Ischemia | CNS Neuroscience and Therapeutics | 2012 | 235 |
14 | Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2 | CNS Neuroscience and Therapeutics | 2020 | 234 |
15 | Altered Processing of Contextual Information during Fear Extinction in PTSD: An fMRI Study | CNS Neuroscience and Therapeutics | 2011 | 232 |
16 | Inhibition of ferroptosis attenuates tissue damage and improves long‐term outcomes after traumatic brain injury in mice | CNS Neuroscience and Therapeutics | 2019 | 226 |
17 | The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties | CNS Neuroscience and Therapeutics | 2008 | 218 |
18 | Peripheral inflammation and blood–brain barrier disruption: effects and mechanisms | CNS Neuroscience and Therapeutics | 2021 | 214 |
19 | Tight Junction in Blood‐Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances | CNS Neuroscience and Therapeutics | 2012 | 213 |
20 | Baicalin mitigates cognitive impairment and protects neurons from microglia‐mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF‐κB signaling pathway | CNS Neuroscience and Therapeutics | 2019 | 213 |
21 | B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin | CNS Neuroscience and Therapeutics | 2020 | 210 |
22 | REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy | CNS Neuroscience and Therapeutics | 2010 | 209 |
23 | The Antiapoptotic Activity of Melatonin in Neurodegenerative Diseases | CNS Neuroscience and Therapeutics | 2009 | 205 |
24 | Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases | CNS Neuroscience and Therapeutics | 2008 | 204 |
25 | Machine learning in major depression: From classification to treatment outcome prediction | CNS Neuroscience and Therapeutics | 2018 | 199 |
26 | Clioquinol: Review of its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders | CNS Neuroscience and Therapeutics | 2012 | 196 |
27 | The Role of Tau in Alzheimer's Disease and Related Disorders | CNS Neuroscience and Therapeutics | 2011 | 195 |
28 | BNIP3 Interacting with LC3 Triggers Excessive Mitophagy in Delayed Neuronal Death in Stroke | CNS Neuroscience and Therapeutics | 2014 | 194 |
29 | Melatonin Stimulates the SIRT1/Nrf2 Signaling Pathway Counteracting Lipopolysaccharide (LPS)‐Induced Oxidative Stress to Rescue Postnatal Rat Brain | CNS Neuroscience and Therapeutics | 2017 | 189 |
30 | Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure | CNS Neuroscience and Therapeutics | 2019 | 186 |
31 | Astrocyte morphology: Diversity, plasticity, and role in neurological diseases | CNS Neuroscience and Therapeutics | 2019 | 186 |
32 | All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors | CNS Neuroscience and Therapeutics | 2011 | 185 |
33 | A brain network model for depression: From symptom understanding to disease intervention | CNS Neuroscience and Therapeutics | 2018 | 184 |
34 | Seizures and Epilepsy in Alzheimer's Disease | CNS Neuroscience and Therapeutics | 2012 | 181 |
35 | Cannabidiol: A Promising Drug for Neurodegenerative Disorders? | CNS Neuroscience and Therapeutics | 2009 | 179 |
36 | The neuroprotective effects of caffeine in neurodegenerative diseases | CNS Neuroscience and Therapeutics | 2017 | 177 |
37 | Oxytocin Levels in Social Anxiety Disorder | CNS Neuroscience and Therapeutics | 2008 | 174 |
38 | RESEARCH: Cognitive Rehabilitation for Bipolar Disorder: An Open Trial for Employed Patients with Residual Depressive Symptoms | CNS Neuroscience and Therapeutics | 2010 | 171 |
39 | Acetylcholine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders | CNS Neuroscience and Therapeutics | 2010 | 164 |
40 | Involvement of Inflammasome Activation in Lipopolysaccharide‐induced Mice Depressive‐like Behaviors | CNS Neuroscience and Therapeutics | 2014 | 160 |
41 | Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track? | CNS Neuroscience and Therapeutics | 2013 | 159 |
42 | Ketamine and Peripheral Inflammation | CNS Neuroscience and Therapeutics | 2013 | 158 |
43 | Biomarkers for the Clinical Differential Diagnosis in Traumatic Brain Injury-A Systematic Review | CNS Neuroscience and Therapeutics | 2013 | 157 |
44 | Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia | CNS Neuroscience and Therapeutics | 2011 | 154 |
45 | A Double‐Edged Sword with Therapeutic Potential: An Updated Role of Autophagy in Ischemic Cerebral Injury | CNS Neuroscience and Therapeutics | 2012 | 153 |
46 | Surgery Upregulates High Mobility Group Box‐1 and Disrupts the Blood–Brain Barrier causing Cognitive Dysfunction in Aged Rats | CNS Neuroscience and Therapeutics | 2012 | 152 |
47 | Mechanisms of Efficacy of CBT for Cambodian Refugees with PTSD: Improvement in Emotion Regulation and Orthostatic Blood Pressure Response | CNS Neuroscience and Therapeutics | 2009 | 147 |
48 | Mechanisms and roles of mitophagy in neurodegenerative diseases | CNS Neuroscience and Therapeutics | 2019 | 145 |
49 | Dopamine and Glutamate in Huntington's Disease: A Balancing Act | CNS Neuroscience and Therapeutics | 2010 | 143 |
50 | Adenosine–Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders | CNS Neuroscience and Therapeutics | 2010 | 141 |